Fukuoka, Japan

Hajime Nagahara

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Panasonic Corporation, Other. Active years: 2014-2022.


% Patents Active = 100.0


Average Co-Inventor Count = 2.5

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Fukuoka, JP (2014 - 2015)
  • Osaka, JP (2022)

Company Filing History:


Years Active: 2014-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Hajime Nagahara: Innovator in Hemoglobin Quantification Technology

Introduction

Hajime Nagahara is a notable inventor based in Fukuoka, Japan. He has made significant contributions to the field of medical technology, particularly in the quantification of hemoglobin. With a total of 3 patents to his name, Nagahara's work focuses on non-invasive methods for assessing the oxygen metabolic state of biological tissues.

Latest Patents

Nagahara's latest patents include a hemoglobin quantification device, a hemoglobin quantification method, and a hemoglobin quantification program. These inventions aim to provide a clear and accurate measurement of hemoglobin levels in biological tissues without the need for invasive procedures. His surgical assistance device further enhances the capabilities of medical professionals in performing precise interventions.

Career Highlights

Throughout his career, Hajime Nagahara has worked with prominent companies, including Panasonic Corporation. His experience in these organizations has allowed him to develop innovative solutions that address critical challenges in medical diagnostics and imaging.

Collaborations

Nagahara has collaborated with esteemed colleagues such as Masayuki Kimura and Tetsuo Ikeda. These partnerships have fostered a creative environment that has led to the advancement of technology in the medical field.

Conclusion

Hajime Nagahara's contributions to hemoglobin quantification technology exemplify the impact of innovation in healthcare. His dedication to developing non-invasive methods has the potential to improve patient outcomes significantly.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…